Cargando…

Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis

INTRODUCTION: Interferon-γ (IFN-γ) is essential for defence against Mycobacterium tuberculosis; however, levels in patients with active tuberculosis (TB) and changes during treatment have not been documented in our tuberculosis patients in Nigeria, hence this study has been carried out. OBJECTIVE: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Adewole, Olanisun Olufemi, Ota, Martin O., Erhabor, Greg E., Owiafe, Patrick, Oladimeji, Aliu, Obaseki, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948958/
https://www.ncbi.nlm.nih.gov/pubmed/24665150
http://dx.doi.org/10.4103/0300-1652.126287
_version_ 1782306861761953792
author Adewole, Olanisun Olufemi
Ota, Martin O.
Erhabor, Greg E.
Owiafe, Patrick
Oladimeji, Aliu
Obaseki, Daniel
author_facet Adewole, Olanisun Olufemi
Ota, Martin O.
Erhabor, Greg E.
Owiafe, Patrick
Oladimeji, Aliu
Obaseki, Daniel
author_sort Adewole, Olanisun Olufemi
collection PubMed
description INTRODUCTION: Interferon-γ (IFN-γ) is essential for defence against Mycobacterium tuberculosis; however, levels in patients with active tuberculosis (TB) and changes during treatment have not been documented in our tuberculosis patients in Nigeria, hence this study has been carried out. OBJECTIVE: To determine variations, treatment kinetics, and predictive value of IFN-γ levels during treatment of active tuberculosis. DESIGN: Patients with pulmonary tuberculosis were recruited and subsequently followed up for 3 months during treatment with anti-TB. Peripheral blood was collected for IFN-γ assays, C-reactive protein and others followed by a Mantoux test. IFN-γ levels produced by stimulation with TB antigens were determined by ELISA and repeated measurement of IFN-γ were done at 1 and 3 months of anti-TB therapy. Chi Associations and correlations between IFN-γ were determined. Regression analysis was done to determine association between serial IFN-γ and treatment outcome. RESULTS: We recruited 47 patients with active tuberculosis with a mean age of 34.8 ± 3.6 years and M:F ratio of 1.12:1. Six (11%) were HIV positive. The mean level of IFN-γ induced by TB antigens was 629 ± 114.1 pg/ml, higher for HIV-negative PTB patients compared with HIV-positive PTB patients, 609.78 ± 723.9 pg/ml and 87.88 ± 130.0 pg/ml, respectively, P-value = 0.000. The mean level of IFN-γ induced by TB antigen increased significantly from 629 ± 114.1 pg/ml to 1023.46 + 222.8 pg/ml, P-value = 0.03 and reduced to 272.3 ± 87.7 pg/ml by the third month on anti-TB drugs, P-value = 0.001. Negative correlation was observed between the mean of baseline and chest X-ray involvement, P = 0.03. There was no significant correlation between sputum smear grade with baseline and follow-up IFN-γ levels. Three-month IFN-γ level among cured patients were higher than those with treatment failure, regression analysis showed that it does not predict outcome. CONCLUSION: IFN-γ may be useful in early detection and monitoring response; however, large scale studies are needed.
format Online
Article
Text
id pubmed-3948958
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39489582014-03-24 Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis Adewole, Olanisun Olufemi Ota, Martin O. Erhabor, Greg E. Owiafe, Patrick Oladimeji, Aliu Obaseki, Daniel Niger Med J Original Article INTRODUCTION: Interferon-γ (IFN-γ) is essential for defence against Mycobacterium tuberculosis; however, levels in patients with active tuberculosis (TB) and changes during treatment have not been documented in our tuberculosis patients in Nigeria, hence this study has been carried out. OBJECTIVE: To determine variations, treatment kinetics, and predictive value of IFN-γ levels during treatment of active tuberculosis. DESIGN: Patients with pulmonary tuberculosis were recruited and subsequently followed up for 3 months during treatment with anti-TB. Peripheral blood was collected for IFN-γ assays, C-reactive protein and others followed by a Mantoux test. IFN-γ levels produced by stimulation with TB antigens were determined by ELISA and repeated measurement of IFN-γ were done at 1 and 3 months of anti-TB therapy. Chi Associations and correlations between IFN-γ were determined. Regression analysis was done to determine association between serial IFN-γ and treatment outcome. RESULTS: We recruited 47 patients with active tuberculosis with a mean age of 34.8 ± 3.6 years and M:F ratio of 1.12:1. Six (11%) were HIV positive. The mean level of IFN-γ induced by TB antigens was 629 ± 114.1 pg/ml, higher for HIV-negative PTB patients compared with HIV-positive PTB patients, 609.78 ± 723.9 pg/ml and 87.88 ± 130.0 pg/ml, respectively, P-value = 0.000. The mean level of IFN-γ induced by TB antigen increased significantly from 629 ± 114.1 pg/ml to 1023.46 + 222.8 pg/ml, P-value = 0.03 and reduced to 272.3 ± 87.7 pg/ml by the third month on anti-TB drugs, P-value = 0.001. Negative correlation was observed between the mean of baseline and chest X-ray involvement, P = 0.03. There was no significant correlation between sputum smear grade with baseline and follow-up IFN-γ levels. Three-month IFN-γ level among cured patients were higher than those with treatment failure, regression analysis showed that it does not predict outcome. CONCLUSION: IFN-γ may be useful in early detection and monitoring response; however, large scale studies are needed. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3948958/ /pubmed/24665150 http://dx.doi.org/10.4103/0300-1652.126287 Text en Copyright: © Nigerian Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Adewole, Olanisun Olufemi
Ota, Martin O.
Erhabor, Greg E.
Owiafe, Patrick
Oladimeji, Aliu
Obaseki, Daniel
Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
title Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
title_full Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
title_fullStr Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
title_full_unstemmed Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
title_short Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
title_sort interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948958/
https://www.ncbi.nlm.nih.gov/pubmed/24665150
http://dx.doi.org/10.4103/0300-1652.126287
work_keys_str_mv AT adewoleolanisunolufemi interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis
AT otamartino interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis
AT erhaborgrege interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis
AT owiafepatrick interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis
AT oladimejialiu interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis
AT obasekidaniel interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis